These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 844900)

  • 41. Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.
    Lobmann M; Delem A; Jovanovic D; Peetermans J
    J Hyg (Lond); 1981 Aug; 87(1):43-52. PubMed ID: 7019320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The "in vivo" production of "new" influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission.
    Webster RG; Campbell CH; Granoff A
    Virology; 1973 Jan; 51(1):149-62. PubMed ID: 4684582
    [No Abstract]   [Full Text] [Related]  

  • 43. The molecular epidemiology of influenza.
    Kilbourne ED
    J Infect Dis; 1973 Apr; 127(4):478-87. PubMed ID: 4121053
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative characteristics of epidemic strains of the influenza virus B isolated in 1980-1981].
    Iakhno MA; Zakstel'skaia LIa; Molibog EV; Ivanova VT; Shenderovich SF
    Vopr Virusol; 1982; 27(6):656-61. PubMed ID: 6186087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
    Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The "in vivo" production of "new" influenza A viruses. I. Genetic recombination between avian and mammalian influenza viruses.
    Webster RG; Campbell CH; Granoff A
    Virology; 1971 May; 44(2):317-28. PubMed ID: 5565817
    [No Abstract]   [Full Text] [Related]  

  • 47. Recent advances in influenza vaccinces.
    Gregg MB
    J Occup Med; 1974 Oct; 16(10):651-3. PubMed ID: 4616070
    [No Abstract]   [Full Text] [Related]  

  • 48. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus.
    Massicot JG; Murphy BR; van Wyke K; Huang KY; Chanock RM
    Virology; 1980 Oct; 106(1):187-90. PubMed ID: 6893373
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunochemistry of variants of influenza virus hemagglutinin and neuraminidase.
    Laver WG
    Adv Exp Med Biol; 1985; 185():149-74. PubMed ID: 3907308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative study on the properties of influenza B viruses isolated in 1959-1974].
    Nekliudova LI; Fedorova IuB; Gumennik AE; Orlova NG
    Vopr Virusol; 1975; (4):458-63. PubMed ID: 1216839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes in the antigenicity of influenza virus neuraminidases due to various methods of preparation].
    Desselberger U
    Fortschr Med; 1978 Mar; 96(9):471-6. PubMed ID: 627393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigenic composition of recombinant virus strains produced from human and avian influenza A viruses.
    Easterday B; Laver WG; Pereira HG; Schild GC
    J Gen Virol; 1969 Jul; 5(1):83-91. PubMed ID: 4980901
    [No Abstract]   [Full Text] [Related]  

  • 53. [Genetic techniques for the production of influenza vaccines (author's transl)].
    Teti G
    Ann Sclavo; 1980; 22(1):34-9. PubMed ID: 7018413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.
    Schild GC; Oxford JS; Dowdle WR; Coleman M; Pereira MS; Chakraverty P
    Bull World Health Organ; 1974; 51(1):1-11. PubMed ID: 4218138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNAs of influenza virus recombinants derived from parents of known virulence for man.
    Florent G; Lobmann M; Beare AS; Zygraich N
    Arch Virol; 1977; 54(1-2):19-28. PubMed ID: 889441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic relationships between strains of influenza B virus.
    Luzyanina TY; Nevedomskaya GN; Taros LY; Kudryavtseva VK; Smorodintsev AA
    Acta Virol; 1979 Mar; 23(2):113-9. PubMed ID: 90457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influenza virus recombination. I. Matrix protein markers and segregation during mixed infections.
    Laver WG; Downie JC
    Virology; 1976 Mar; 70(1):105-17. PubMed ID: 1258372
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombination of influenza A virus strains: effect on pathogenicity.
    Ennis FA; Verbonitz M; Reichelderfer P; Daniel S
    Dev Biol Stand; 1976; 33():220-5. PubMed ID: 955268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The molecular basis of antigenic variation in influenza virus.
    Air GM; Laver WG
    Adv Virus Res; 1986; 31():53-102. PubMed ID: 2428216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.